홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Diisopropylethylamine → N-(6-Bromo-1H-indazol-4-yl)-2-pyridinecarboxamide

HRID 1695718
인쇄

반응식

HRID 1695718 반응식
[Br:1][C:2]1[CH:3]=[C:4]([NH2:11])[C:5]2[CH:6]=[N:7][NH:8][C:9]=2[CH:10]=1.Cl.[N:13]1[CH:18]=[CH:17][CH:16]=[CH:15][C:14]=1[C:19](Cl)=[O:20].CCN(C(C)C)C(C)C>C(Cl)Cl>[Br:1][C:2]1[CH:10]=[C:9]2[C:5]([CH:6]=[N:7][NH:8]2)=[C:4]([NH:11][C:19]([C:14]2[CH:15]=[CH:16][CH:17]=[CH:18][N:13]=2)=[O:20])[CH:3]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 81531DiisopropylethylamineHCID 135033Picolinoyl Chloride HydrochlorideHCID 247280636-Bromo-1H-indazol-4-amine

생성물 1

HCID 58255852N-(6-Bromo-1H-indazol-4-yl)-2-pyridinecarboxamide

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

6-Bromo-1H-indazol-4-amine (100 mg, 0.47 mmol), 2-pyridinecarbonyl chloride hydrochloride (100 mg, 0.56 mmol) and DIPEA (0.164 ml, 0.94 mmol) were stirred in DCM (10 ml) at RT overnight. The reaction was concentrated in vacuo. The residue was purified by MDAP (Method B) and appropriate fractions were evaporated to give the title compound, 38 mg.

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트

후처리

  1. concentrationThe reaction was concentrated in vacuo
  2. customThe residue was purified by MDAP (Method B) and appropriate fractions
  3. customwere evaporated

출처 및 근거

ORD 기록
ord-942ef56db10c40e09c283f66ace3f07f
출처 데이터셋
uspto-grants-2012_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08163743B2

반응 노트